Poland· PL-100113965
PlantagoPharm
A medicinal product containing plantaginis lanceolatae folii extractum fluidum, registered in Poland by Phytopharm Klęka S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Plantaginis lanceolatae folii extractum fluidum
- Manufacturer
- Phytopharm Klęka S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990998111
- gtin05909990998128
- gtin05909991185114
- gtin05909991185121
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4732bbc-0195-44a6-a349-00f400714452 GET /v1/drugs/b4732bbc-0195-44a6-a349-00f400714452?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Syrop",
"source": "urpl",
"strength": "506 mg/5 ml",
"packaging": "05909990998111 ¦ OTC ¦ Skasowane ¦ 20657\n1 butelka 150 g\n05909990998128 ¦ OTC ¦ Skasowane ¦ 27948\n1 butelka 100 ml\n05909991185114 ¦ OTC ¦ 103244\n1 butelka 100 ml\n05909991185121 ¦ OTC ¦ 103245\n1 butelka 200 ml",
"substance": "Plantaginis lanceolatae herbae extractun fluidum (1:1) 8 g",
"common_name": "Plantaginis lanceolatae folii extractum fluidum",
"pl_product_id": "100113965",
"pozwolenie_nr": "09981",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about plantaginis lanceolatae folii extractum fluidum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.